MX2021012966A - Cas9 diseñado con intervalo de dirección de adn ampliado. - Google Patents

Cas9 diseñado con intervalo de dirección de adn ampliado.

Info

Publication number
MX2021012966A
MX2021012966A MX2021012966A MX2021012966A MX2021012966A MX 2021012966 A MX2021012966 A MX 2021012966A MX 2021012966 A MX2021012966 A MX 2021012966A MX 2021012966 A MX2021012966 A MX 2021012966A MX 2021012966 A MX2021012966 A MX 2021012966A
Authority
MX
Mexico
Prior art keywords
broadened
cas9
dna targeting
variant
engineered cas9
Prior art date
Application number
MX2021012966A
Other languages
English (en)
Spanish (es)
Inventor
Le Cong
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of MX2021012966A publication Critical patent/MX2021012966A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2021012966A 2019-04-25 2020-04-24 Cas9 diseñado con intervalo de dirección de adn ampliado. MX2021012966A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962838498P 2019-04-25 2019-04-25
PCT/US2020/029855 WO2020219908A1 (en) 2019-04-25 2020-04-24 Engineered cas9 with broadened dna targeting range

Publications (1)

Publication Number Publication Date
MX2021012966A true MX2021012966A (es) 2022-04-06

Family

ID=72941444

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021012966A MX2021012966A (es) 2019-04-25 2020-04-24 Cas9 diseñado con intervalo de dirección de adn ampliado.

Country Status (12)

Country Link
US (1) US20220204954A1 (cg-RX-API-DMAC7.html)
EP (1) EP3958914A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022530055A (cg-RX-API-DMAC7.html)
KR (1) KR20220025708A (cg-RX-API-DMAC7.html)
CN (1) CN114206394A (cg-RX-API-DMAC7.html)
AU (1) AU2020261071A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021021306A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137903A1 (cg-RX-API-DMAC7.html)
IL (1) IL287541A (cg-RX-API-DMAC7.html)
MX (1) MX2021012966A (cg-RX-API-DMAC7.html)
SG (1) SG11202111814XA (cg-RX-API-DMAC7.html)
WO (1) WO2020219908A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
US20230295611A1 (en) * 2022-03-01 2023-09-21 Versitech Limited Cas9 protein for genome editing
CN115083532B (zh) * 2022-06-21 2024-08-27 中国科学技术大学 基于分子动力学模拟获取rsv f突变体的方法
CN115927439B (zh) * 2022-08-29 2026-04-21 中国农业科学院作物科学研究所 CRISPR/SaCas9系统在大豆基因编辑中的应用
AU2024309386A1 (en) 2023-06-30 2025-12-18 Christiana Care Gene Editing Institute, Inc. Nras gene knockout for treatment of cancer
CN117866926B (zh) * 2024-03-07 2024-08-16 珠海舒桐医疗科技有限公司 一种CRISPR-FrCas9蛋白突变体及应用
WO2025213016A2 (en) 2024-04-04 2025-10-09 Christiana Care Gene Editing Institute, Inc. Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
WO2025226816A1 (en) 2024-04-23 2025-10-30 Christiana Care Gene Editing Institute, Inc. Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016226077B2 (en) * 2015-03-03 2021-12-23 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases with altered PAM specificity
WO2016205759A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
US9512446B1 (en) * 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
WO2018027078A1 (en) * 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
KR102569848B1 (ko) * 2016-12-23 2023-08-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Pcsk9의 유전자 편집
JP6628387B2 (ja) * 2017-09-05 2020-01-08 国立大学法人 東京大学 改変されたCas9タンパク質及びその用途

Also Published As

Publication number Publication date
CN114206394A (zh) 2022-03-18
AU2020261071A1 (en) 2021-11-25
US20220204954A1 (en) 2022-06-30
EP3958914A4 (en) 2023-07-19
BR112021021306A2 (pt) 2022-02-01
CA3137903A1 (en) 2020-10-29
WO2020219908A1 (en) 2020-10-29
KR20220025708A (ko) 2022-03-03
SG11202111814XA (en) 2021-11-29
EP3958914A1 (en) 2022-03-02
IL287541A (en) 2021-12-01
JP2022530055A (ja) 2022-06-27

Similar Documents

Publication Publication Date Title
EP4253551A3 (en) Novel crispr dna and rna targeting enzymes and systems
ZA202202628B (en) Novel crispr dna targeting enzymes and systems
BR112021021306A2 (pt) Ecas9 modificada com ampliação da faixa de alvo de dna
WO2019006471A3 (en) NOVEL CRISPR RNA TARGETING ENZYMES, SYSTEMS AND USES THEREOF
WO2020086144A3 (en) APPLICATIONS OF CRISPRi IN HIGH THROUGHPUT METABOLIC ENGINEERING
WO2019009682A3 (ko) 표적 특이적 crispr 변이체
EP4361261A3 (en) Novel cas13b orthologues crispr enzymes and systems
MX2022012110A (es) Sistemas crispr clase ii tipo ii.
MX2024006956A (es) Inserciones de adn no virales orientadas.
PL3765615T3 (pl) Nowe enzymy i układy crispr ukierunkowane na dna
WO2018195545A3 (en) Variants of cpf1 (cas12a) with altered pam specificity
SG10201805815YA (en) Rna-guided gene drives
MX2020011939A (es) Nuevas enzimas y sistemas crispr.
GB2569734A (en) RNA-guided nucleic acid modifying enzymes and methods of use thereof
MX2018001617A (es) Composiciones de crispr-cas9 diseñados y metodos de uso.
EP4434589A3 (en) Evolved cas9 proteins for gene editing
PH12021550256A1 (en) Novel crispr-associated protein and use thereof
MX2022002919A (es) Nuevas endonucleasas guiadas por rna crispr-cas tipo ii y tipo v de clase 2.
EP4385567A3 (en) Methods and compositions for rna-guided treatment of hiv infection
EP4025588A4 (en) NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
EP3996738A4 (en) NOVEL ENZYMES AND SYSTEMS TARGETING CRISPR DNA
EP4021924A4 (en) NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
EP3983536A4 (en) NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
WO2017100431A3 (en) Gene editing methods and compositions for eliminating risk of jc virus activation and pml (progressive multifocal leukoencephalopathy) during immunosuppresive therapy
WO2018057946A3 (en) Tuning crispr/cas9 activity with chemically modified nucleotide substitutions